Body part harvesting company sold parts from dead cancer patients, drug users for use in surgery recipients

Email this article to a friend

Printable Version

Articles Related to This Article: • Funeral home directors conspired to steal body parts from cadavers, then sell to biomedical supply companies • Global trade in human organs expands as cash buys body parts from prisoners, cadavers • Organ transplant industry pushes for legal right to buy and sell body parts on the global market Support NaturalNews advertisers - Advertise with NaturalNews Help support NaturalNews with health books and educational programs from Truth Publishing: • Swine Flu Advanced Preparedness • 8 Weeks to Vibrant Health • Raw In Ten Minutes (recipes) • How to Halt Diabetes in 25 Days ... and much more.

(NaturalNews) The Food and Drug Administration (FDA) ordered a North Carolina company that harvests human body parts for transplant to close last week after finding serious violations in the company's donor-screening and record-keeping practices.

The company -- Donor Referral Services -- was ordered to stop its operations after FDA inspections of the Raleigh-based company in June revealed doctored records that had allowed former cancer patients and intravenous drug users to have their organs harvested for transplant.

In the case of at least five of the cadavers at the company, paperwork had been altered on the age and history of the donors. In one case, the company's owner, Philip Guyette, failed to list that the donor had died of cancer, and that intravenous drug use had been a factor in the death. Use of IV drugs increases the risk of HIV/AIDS and hepatitis.

Though all of the tissues the company harvested have been recalled, the FDA says some have already been transplanted. FDA spokesman Paul Richards was unclear on how many people had received tissue from the company, and urged patients who had questions to contact their doctors.

"Allowing the firm to continue to manufacture would present a danger to public health by increasing the risk of communicable disease transmission," says Margaret O'K. Glavin, associate commissioner of the FDA's office of regulatory affairs.

The Donor Referral Services shutdown comes after the tissue industry has struggled to recover from its biggest scandal, which involved a New Jersey company -- Biomedical Tissue Services -- allegedly taking body parts from corpses without the families' permission.

"The organ harvesting industry is shrouded in secrecy," said Mike Adams, consumer health advocate, "but the secrets are starting to come out, and what we're learning is horrifying. The body parts trade is steeped in unethical and grotesque practices, and it profits from the trade of human organs of taken from questionable sources under suspicious circumstances."

Adams has long been an outspoken critic of the profit motive in the organ donor / organ harvesting industries and warns people to think twice before becoming an organ donor. "There are even laws on the books in some countries," he explains, "that allow surgeons to start prepping your body for organ harvesting before you've been declared dead."

###

Share

Get articles like this delivered to you FREE in our popular email newsletter

Related CounterThink Cartoons:

Related Articles: • Funeral home directors conspired to steal body parts from cadavers, then sell to biomedical supply companies • Global trade in human organs expands as cash buys body parts from prisoners, cadavers • Organ transplant industry pushes for legal right to buy and sell body parts on the global market	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/020109_body_parts_cancer_medical_ethics.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. Embed article link: (copy HTML code below): <a href = "http://www.NaturalNews.com/020109_body_parts_cancer_medical_ethics.html">Body part harvesting company sold parts from dead cancer patients, drug users for use in surgery recipients</a>